Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313455228> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4313455228 endingPage "132" @default.
- W4313455228 startingPage "127" @default.
- W4313455228 abstract "Synthetic adrenocorticotropic hormone or tetracosactide is routinely used in the diagnosis of hypoadrenocorticism and frequently in the diagnosis and treatment of hyperadrenocorticism. There have been repeated shortages of tetracosactide in recent years in Australia. This study investigated the agreement of serum cortisol after a compounded tetracosactide (Bova Aus), compared to commercial tetracosactide (Synacthen®) in healthy dogs.Prospective crossover study using 20 dogs. Ten dogs received 5 μg/kg Synacthen® on day 1 and 5 μg/kg compounded tetracosactide on Day 2. The other 10 dogs received the reverse order. Cortisol concentrations in each dog 1 h after injection were compared for agreement, which was defined as the limits of agreement of the Bland-Altman ratio to be within a range of 0.8-1.25. Passing-Bablok regression analysis examined for constant and proportional biases.Three dogs were excluded with post-stimulation serum cortisol concentrations markedly outside reference interval. For the remaining 17 dogs, Bland-Altman ratio analysis of cortisol concentration (tetracosactide/Synacthen®) at 1 h found virtually no constant bias (mean of ratios 1.01;95% CI 0.97-1.05) and 95% limits of agreement were 0.88 (95% CI 0.78-0.90) and 1.17 (95% CI 1.13-1.25). This met our criteria for agreement between cortisol concentrations. Bias of the Bland-Altman difference was 2.8 nmol/L (95% CI -7.2 to 12.8); 95% limits of agreement -35.2 nmol/L (95% CI -57.0 to -26.1) and 40.8 nmol/L (95% CI 31.7-62.6). Passing-Bablok regression analysis did not identify bias.In healthy dogs, cortisol concentrations were in agreement after compounded tetracosactide compared to commercial tetracosactide, Synacthen®." @default.
- W4313455228 created "2023-01-06" @default.
- W4313455228 creator A5011929219 @default.
- W4313455228 creator A5013248675 @default.
- W4313455228 creator A5022404489 @default.
- W4313455228 creator A5042266343 @default.
- W4313455228 creator A5062554875 @default.
- W4313455228 creator A5066931395 @default.
- W4313455228 date "2023-01-03" @default.
- W4313455228 modified "2023-09-26" @default.
- W4313455228 title "Assessment of a compounded synthetic adrenocorticotropic hormone product in 17 healthy dogs" @default.
- W4313455228 cites W1984599751 @default.
- W4313455228 cites W2031867077 @default.
- W4313455228 cites W2033550635 @default.
- W4313455228 cites W2041800117 @default.
- W4313455228 cites W2047622641 @default.
- W4313455228 cites W2159759971 @default.
- W4313455228 cites W2173932786 @default.
- W4313455228 cites W2322807564 @default.
- W4313455228 cites W2500906381 @default.
- W4313455228 cites W4229753260 @default.
- W4313455228 doi "https://doi.org/10.1111/avj.13225" @default.
- W4313455228 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36594371" @default.
- W4313455228 hasPublicationYear "2023" @default.
- W4313455228 type Work @default.
- W4313455228 citedByCount "0" @default.
- W4313455228 crossrefType "journal-article" @default.
- W4313455228 hasAuthorship W4313455228A5011929219 @default.
- W4313455228 hasAuthorship W4313455228A5013248675 @default.
- W4313455228 hasAuthorship W4313455228A5022404489 @default.
- W4313455228 hasAuthorship W4313455228A5042266343 @default.
- W4313455228 hasAuthorship W4313455228A5062554875 @default.
- W4313455228 hasAuthorship W4313455228A5066931395 @default.
- W4313455228 hasConcept C126322002 @default.
- W4313455228 hasConcept C134018914 @default.
- W4313455228 hasConcept C142724271 @default.
- W4313455228 hasConcept C204787440 @default.
- W4313455228 hasConcept C27081682 @default.
- W4313455228 hasConcept C2780546910 @default.
- W4313455228 hasConcept C44249647 @default.
- W4313455228 hasConcept C71315377 @default.
- W4313455228 hasConcept C71924100 @default.
- W4313455228 hasConcept C87813604 @default.
- W4313455228 hasConcept C90924648 @default.
- W4313455228 hasConceptScore W4313455228C126322002 @default.
- W4313455228 hasConceptScore W4313455228C134018914 @default.
- W4313455228 hasConceptScore W4313455228C142724271 @default.
- W4313455228 hasConceptScore W4313455228C204787440 @default.
- W4313455228 hasConceptScore W4313455228C27081682 @default.
- W4313455228 hasConceptScore W4313455228C2780546910 @default.
- W4313455228 hasConceptScore W4313455228C44249647 @default.
- W4313455228 hasConceptScore W4313455228C71315377 @default.
- W4313455228 hasConceptScore W4313455228C71924100 @default.
- W4313455228 hasConceptScore W4313455228C87813604 @default.
- W4313455228 hasConceptScore W4313455228C90924648 @default.
- W4313455228 hasIssue "4" @default.
- W4313455228 hasLocation W43134552281 @default.
- W4313455228 hasLocation W43134552282 @default.
- W4313455228 hasOpenAccess W4313455228 @default.
- W4313455228 hasPrimaryLocation W43134552281 @default.
- W4313455228 hasRelatedWork W1875915725 @default.
- W4313455228 hasRelatedWork W1983459621 @default.
- W4313455228 hasRelatedWork W2001940865 @default.
- W4313455228 hasRelatedWork W2012379850 @default.
- W4313455228 hasRelatedWork W2031234973 @default.
- W4313455228 hasRelatedWork W2061601189 @default.
- W4313455228 hasRelatedWork W2085915164 @default.
- W4313455228 hasRelatedWork W2086864221 @default.
- W4313455228 hasRelatedWork W2171647298 @default.
- W4313455228 hasRelatedWork W2403860533 @default.
- W4313455228 hasVolume "101" @default.
- W4313455228 isParatext "false" @default.
- W4313455228 isRetracted "false" @default.
- W4313455228 workType "article" @default.